IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.07-1610 on April 17, 2008
(Investigative Ophthalmology and Visual Science. 2008;49:3955-3960.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.07-1610

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.07-1610v1
49/9/3955    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer-ter-Vehn, T.
Right arrow Articles by Schlunck, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer-ter-Vehn, T.
Right arrow Articles by Schlunck, G.

Lovastatin Inhibits TGF-β–Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts

Tobias Meyer-ter-Vehn,* Barbara Katzenberger, Hong Han, Franz Grehn, and Günther Schlunck*

From the Department of Ophthalmology, University of Würzburg, Würzburg, Germany.

PURPOSE. The transdifferentiation of Tenon fibroblasts to myofibroblasts is a pivotal step in filtering bleb scarring. It is mediated by the cytokine TGF-β, Rho-dependent contractility, and cell–matrix interactions in an interdependent fashion. HMG-CoA-reductase inhibitors (statins) have been shown to inhibit Rho-GTPase signaling; therefore, the authors studied the influence of lovastatin on TGF-β–mediated myofibroblast transdifferentiation to assess the potential use of statins in wound healing modulation.

METHODS. Human Tenon fibroblasts were grown in culture, pretreated with lovastatin, lovastatin and mevalonate, or specific inhibitors of farnesyl transferase or geranylgeranyl transferase and were stimulated with TGF-β1. {alpha}-Smooth muscle actin ({alpha}-SMA) and connective tissue growth factor (CTGF) transcription were assessed by real-time PCR. {alpha}-SMA protein expression and localization were studied by Western blot and confocal immunofluorescence microscopy. Cell contractility was determined in collagen gel contraction assays. Phosphorylation of the signaling proteins Smad-2/3 and p38 were detected by Western blot, and Smad-2/3 localization was determined by confocal immunofluorescence microscopy.

RESULTS. Lovastatin inhibited TGF-β–induced CTGF transcription, {alpha}-SMA expression and incorporation into actin stress fibers, and subsequent collagen gel contraction. These effects were reversed by mevalonate. The inhibition of geranylgeranyl transferase but not farnesyl transferase blocked TGF-β–induced {alpha}-SMA expression. Lovastatin decreased TGF-β–induced p38 activation, whereas Smad-2/3 phosphorylation and nuclear translocation were preserved.

CONCLUSIONS. Lovastatin inhibits TGF-β–induced myofibroblast transdifferentiation in human Tenon fibroblasts, most likely by interfering with Rho-signaling. Statins may, therefore, serve to inhibit scarring after filtering glaucoma surgery.





This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. A. Benton, H. B. Kern, L. A. Leinwand, P. D. Mariner, and K. S. Anseth
Statins Block Calcific Nodule Formation of Valvular Interstitial Cells by Inhibiting {alpha}-Smooth Muscle Actin Expression
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1950 - 1957.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology